𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Extensor digitorum brevis test and resistance to botulinum toxin type A

✍ Scribed by Paul H. Gordon; Clifton L. Gooch; Paul E. Greene


Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
63 KB
Volume
26
Category
Article
ISSN
0148-639X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Secondary nonresponsiveness to botulinum
✍ Carla Cordivari; Vijay Peter Misra; Angela Vincent; Santiago Catania; Kailash P. πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 125 KB

## Abstract We studied 20 patients with cervical dystonia who had started to respond poorly to botulinum toxin A (BTXA) injections after an initial good response. All patients had extensor digitorum brevis (EDB) tests performed in addition to BTXA immunoprecipition assay (IPA) and mouse bioassay (M

In vivo analysis of end-plate noise of h
✍ M.J.A.M. Van Putten; M. Padberg; D.L.J. Tavy πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 102 KB

## Abstract To evaluate changes occurring in the neuromuscular junction after injection with botulinum neurotoxin type A (BoTx), three healthy volunteers were injected with 10 U BoTx in the right extensor digitorum brevis muscle. In agreement with previous observations, amplitude of compound muscle

Reduced potency after refrigerated stora
✍ Nam-Jong Paik; Kyle Seo; Hee Chul Eun πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 76 KB

## Abstract To determine whether the potency of botulinum toxin A (BTA) decreases after being reconstituted with normal saline and stored in refrigerator, we injected one side of the extensor digitorum brevis muscle with 2.5 units of botulinum toxin A that had been immediately reconstituted with sa

Development of resistance to botulinum t
✍ Dr. Paul Greene; Stanley Fahn; Beverly Diamond πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 453 KB

## Abstract Between 1984 and 1992, 559 patients with torticollis were treated with botulinum toxin type A (btx) injections. Twenty‐four of these 559 patients (4.3%) had serological evidence of antibodies to btx by mouse neutralization assay. Some of the 559 patients had only one or two injection se

BotB (botulinum Toxin type B): Evaluatio
✍ Dr. Daniel D. Truong; Paul A. Cullis; Christopher F. O'Brien; Martin Koller; Tim πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 314 KB

## Abstract Botulinum toxin (BTX) injection is considered the treatment of choice for patients with cervical dystonia (torticollis). We conducted a pilot, open‐label, dose‐escalation study with BTX type B in 12 patients who no longer responded clinically to injections with BTX type A. At the doses

The EDB Testβ€”A clinical test for the det
✍ Kirn R. Kessler; Dr. Reiner Benecke πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 427 KB

## Abstract Approximately 5 to 10% of patients with cervical, segmental or multifocal dystonia receiving repetitive local injections with botulinum toxin A (BTX A) are estimated to develop secondary loss of treatment benefit (nonresponding) because of the formation of circulating serum antibodies a